The Universal Telemetry Layer: Why Implicity's Cross-Vendor Remote Cardiac Platform Raised $40M
Dr. Dereck Mush, MD, MBA
What they do
VivaLNK manufactures wearable patch sensors and provides a connected cloud platform for remote patient monitoring. Healthcare providers and pharmaceutical researchers use their flexible, continuous ECG patches to track patient cardiac data during clinical trials and post-discharge recovery.
The record
- Vertical
- Cardiovascular
- Sub-segment
- Remote cardiac monitoring
- Product type
- Device
- Stage
- Series B
- Headquarters
- Campbell, USA
- Region
- North America
- Founded
- 2014
- Total funding
- $20M raised
Notable investors: Alumni Ventures Group, Biomedical Funds, Monarch Ventures.
Also in Cardiovascular
Related on The Signal
Dr. Dereck Mush, MD, MBA
From Remote Telemetry to Active Co-Management: Direct-to-Patient Hemodynamics in Heart Failure
Dr. Dereck Mush, MD, MBA
Hardware Tiering and AI Coaching: How Google's Fitbit Edge Reshapes Continuous Monitoring Economics
Dr. Dereck Mush, MD, MBA
Top 25 Cardiologists to Follow on LinkedIn in 2026
Dr. Dereck Mush, MD, MBA